Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 20;40(12):111373.
doi: 10.1016/j.celrep.2022.111373.

cis interaction of CD153 with TCR/CD3 is crucial for the pathogenic activation of senescence-associated T cells

Affiliations
Free article

cis interaction of CD153 with TCR/CD3 is crucial for the pathogenic activation of senescence-associated T cells

Yuji Fukushima et al. Cell Rep. .
Free article

Abstract

With age, senescence-associated (SA) CD4+ T cells that are refractory to T cell receptor (TCR) stimulation are increased along with spontaneous germinal center (Spt-GC) development prone to autoantibody production. We demonstrate that CD153 and its receptor CD30 are expressed in SA-T and Spt-GC B cells, respectively, and deficiency of either CD153 or CD30 results in the compromised increase of both cell types. CD153 engagement on SA-T cells upon TCR stimulation causes association of CD153 with the TCR/CD3 complex and restores TCR signaling, whereas CD30 engagement on GC B cells induces their expansion. Administration of an anti-CD153 antibody blocking the interaction with CD30 suppresses the increase in both SA-T and Spt-GC B cells with age and ameliorates lupus in lupus-prone mice. These results suggest that the molecular interaction of CD153 and CD30 plays a central role in the reciprocal activation of SA-T and Spt-GC B cells, leading to immunosenescent phenotypes and autoimmunity.

Keywords: B cells; CD153; CD30; CD4(+) T cells; CP: Immunology; T cell receptor; aging; autoimmune disease; spontaneous germinal center.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Y.F., M.C., and M.H. are employed by the Immunosenescence Project, which is a collaboration project between Kyoto University and Ono Pharmaceutical Co. Ltd.

Publication types